Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections

Liver International

Volumn 32, Issue 4, 2012, Pages 603-611

  Papp, Maria ^a   Vitalis, Zsuzsanna ^a   Altorjay, Istvan ^a   Tornai, Istvan ^a   Udvardy, Miklos ^a   Harsfalvi, Jolan ^a   Vida, Andras ^a   Kappelmayer, Janos ^a   Lakatos, Peter L ^b   Antal Szalmas, Peter ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Acute phase proteins; Bacterial infection; Cirrhosis

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CD14 ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; DIAGNOSTIC ACCURACY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREDICTION; SENSITIVITY ANALYSIS;

ACUTE-PHASE PROTEINS; ADULT; AGED; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CALCITONIN; CARRIER PROTEINS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIKELIHOOD FUNCTIONS; LIVER CIRRHOSIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; REGRESSION ANALYSIS; ROC CURVE;

EID: 84858218940     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02689.x     Document Type: Article

References (38)

1. Borzio M, Salerno F, Piantoni L, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33: 41-8.
2. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26-42.
3. Thalheimer U, Triantos CK, Samonakis DN, et al. Infection, coagulation, and variceal bleeding in cirrhosis. Gut 2005; 54: 556-63.
4. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18: 353-8.
5. Wong F, Bernardi M, Balk R, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005; 54: 718-25.
6. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
7. Bota DP, Van Nuffelen M, Zakariah AN, et al. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 2005; 146: 347-51.
8. Albillos A, de la Hera A, González M, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208-17.
9. Márquez M, Fernández-Gutiérrez C, Montes-de-Oca M, et al. Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis. Clin Exp Immunol 2009; 158: 219-29.
10. Tsiakalos A, Karatzaferis A, Ziakas P, et al. Acute-phase proteins as indicators of bacterial infection in patients with cirrhosis. Liver Int 2009; 29: 1538-42.
11. Elefsiniotis IS, Skounakis M, Vezali E, et al. Clinical significance of serum procalcitonin levels in patients with acute or chronic liver disease. Eur J Gastroenterol Hepatol 2006; 18: 525-30.
12. Viallon A, Zeni F, Pouzet V, et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med 2000; 26: 1082-8.
13. Lin ZY, Chuang WL, Dai CY, et al. Clinical application of serum C-reactive protein measurement in the detection of bacterial infection in patients with liver cirrhosis. Kaohsiung J Med Sci 2002; 18: 121-6.
14. Altorjay I, Vitalis Z, Tornai I, et al. Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis. J Hepatol 2010; 53: 484-91.
15. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41: 422-33.
16. Saab S, Hernandez JC, Chi AC, et al. Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis. Am J Gastroenterol 2009; 104: 993-1001.
17. Albillos A, Hera Ad Ade L, Reyes E, et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J Hepatol 2004; 40: 624-31.
18. Albillos A, de-la-Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 2004; 363: 1608-10.
19. Zapater P, Francés R, González-Navajas JM, et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. J Hepatol 2008; 48: 1924-31.
20. El-Naggar MM, Khalil El SA, El-Daker MA, et al. Bacterial DNA and its consequences in patients with cirrhosis and culture-negative, non-neutrocytic ascites. J Med Microbiol 2008; 57: 1533-8.
21. Papp M, Norman GL, Vitalis Z, et al. Presence of anti microbial antibodies in liver cirrhosis-a tell-tale sign of compromised immunity? PLoS ONE 2010; 5: e12957.
22. Lakatos PL, Papp M, Rieder F. Serologic Antiglycan Antibodies in Inflammatory Bowel Disease. Am J Gastroenterol 2011; 106: 406-12.
23. Carey E, Carey WD. Noninvasive tests for liver disease, fibrosis, and cirrhosis: is liver biopsy obsolete? Cleve Clin J Med 2010; 8: 519-27.
24. Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol 2005; 42: S100-7.
25. Runyon BA. Ascitic fluid and serum C-reactive protein concentrations in patients with and without peritonitis. Am J Clin Pathol 1986; 86: 773-5.
26. Li CH, Yang RB, Pang JH, et al. Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department. Acad Emerg Med 2011; 18: 121-6.
27. Spahr L, Morard I, Hadengue A, et al. Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatogastroenterology 2001; 48: 502-5.
28. Connert S, Stremmel W, Elsing C. Procalcitonin is a valid marker of infection in decompensated cirrhosis. Z Gastroenterol 2003; 41: 165-70.
29. Simon L, Gauvin F, Amre DK, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-17.
30. Christ-Crain M, Müller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly 2005; 135: 451-60.
31. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36: 941-52.
32. Campos J, Gonzalez-Quintela A, Quinteiro C, et al. The-159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers. Alcohol Clin Exp Res 2005; 29: 1206-13.
33. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med 2007; 33: 1025-32.
34. Sakr Y, Burgett U, Nacul FE, et al. Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis? Crit Care Med 2008; 36: 2014-22.
35. Tschaikowsky K, Hedwig-Geissing M, Braun GG, et al. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2011; 26: 54-64.
36. Distefano G, Curreri R, Betta P, et al. Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants. Acta Paediatr 2004; 93: 216-9.
37. Cirera I, Bauer TM, Navasa M, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34: 32-7.
38. Garcia-Tsao G, Lee FY, Barden GE, et al. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995; 108: 1835-41.